Back to results
US 2022/0089770 A1Published application
Novel cancer antigens and antibodies of said antigens
OwnerJunichi NEZU, Tatsushi KODAMA +5inventors
InventorsJunichi NEZU, Tatsushi KODAMA, Mayumi HOSHINO, Naoki KIMURA, Kohji NAGANO, Kuniyasu KATO, Yukari YOKOTA
Life of this patent
Estimating the term…
Abstract
In a non-limiting embodiment, isolated antibodies that bind to any of the following proteins are provided: XPR1, NOX1, MARVELD3 isoform 1, MARVELD3 isoform 2, SPINT2, MANSC1, SLC12A2, CDCP1, SEZ6L2, FLVCR1, SLC7A5, STEAP1, MMP14, TNFRSF21, and TMPRSS4.
Claims15
An isolated antibody that binds to any of the following proteins:
- XPR1, NOX1, MARVELD3 isoform 1, MARVELD3 isoform 2, SPINT2, MANSC1, SLC12A2, CDCP1, SEZ6L2, FLVCR1, SLC7A5, STEAP1, MMP14, TNFRSF21, and TMPRSS4.
Dependencies are inferred from the claim text.